{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:51:58Z","timestamp":1793451118594,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.ijantimicag.2009.05.003","type":"journal-article","created":{"date-parts":[[2009,6,13]],"date-time":"2009-06-13T05:13:32Z","timestamp":1244870012000},"page":"457-461","source":"Crossref","is-referenced-by-count":104,"title":["Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models"],"prefix":"10.1016","volume":"34","author":[{"given":"Evelina","family":"Rubinchik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Dugourd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Algara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Pasetka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. David","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2009.05.003_bib1","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/AAC.01475-07","article-title":"Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections","volume":"52","author":"Fritsche","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.05.003_bib2","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/jac\/dkn074","article-title":"Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections","volume":"61","author":"Fritsche","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2009.05.003_bib3","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/AAC.48.8.3112-3118.2004","article-title":"Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity","volume":"48","author":"Sader","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2009.05.003_bib4","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jama.271.20.1598","article-title":"Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality","volume":"271","author":"Pittet","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2009.05.003_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(97)10006-X","article-title":"Intravascular-catheter-related infections","volume":"351","author":"Raad","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2009.05.003_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1067\/mic.2002.129427","article-title":"Guidelines for the prevention of intravascular catheter-related infections","volume":"30","author":"O\u2019Grady","year":"2002","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2009.05.003_bib7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-132-5-200003070-00009","article-title":"Prevention of intravascular catheter-related infections","volume":"132","author":"Mermel","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2009.05.003_bib8","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 7th ed. Document M7-A7. Wayne, PA: CLSI; 2006."},{"key":"10.1016\/j.ijantimicag.2009.05.003_bib9","unstructured":"National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. 2nd ed. Document M27-A2. Wayne, PA: NCCLS; 2002."},{"key":"10.1016\/j.ijantimicag.2009.05.003_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/157489106777452638","article-title":"Omiganan pentahydrochloride in the front line of clinical applications of antimicrobial peptides","volume":"1","author":"Melo","year":"2006","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"10.1016\/j.ijantimicag.2009.05.003_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1574-6968.2002.tb11000.x","article-title":"Role of membranes in the activities of antimicrobial cationic peptides","volume":"206","author":"Hancock","year":"2002","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2009.05.003_bib12","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.bbamem.2007.02.005","article-title":"Omiganan interaction with bacterial membranes and cell wall models. Assigning a biological role to saturation","volume":"1768","author":"Melo","year":"2007","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2009.05.003_bib13","series-title":"Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)","article-title":"In-vitro resistance development of clinically relevant bacteria to omiganan pentahydrochloride","author":"Hoban","year":"2003"},{"key":"10.1016\/j.ijantimicag.2009.05.003_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/112972980800900106","article-title":"Risk factors for yeast superinfection in the treatment of suspected exit site infections: a case\u2013control study","volume":"9","author":"Oliveira","year":"2008","journal-title":"J Vasc Access"},{"key":"10.1016\/j.ijantimicag.2009.05.003_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/ajkd.2002.30553","article-title":"Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis","volume":"39","author":"Perez-Fontan","year":"2002","journal-title":"Am J Kidney Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909002209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909002209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T18:05:02Z","timestamp":1558375502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857909002209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0924857909002209"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.05.003","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}